Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
Willis Towers Watson Accuses Lockton of ‘Smash and Grab’ of Construction Team 
Farmers Embrace AI More Than Any Other Tech, McKinsey Says 
25 Years Later: IJ’s Past and Continued Coverage of the Insurance Impact of 9/11 
Amazon Seen as Shielded From Liability for Miami Cargo Plane Crash 
